Effects of Pravastatin on the Apoptosis of Human Mesenchymal Stem Cells Induced by H_2O_2

LIN Haihong,LUO Xinping,SHI Haiming,GONG Hui
2012-01-01
Abstract:Objective:To investigate the effects of pravastatin on the apoptosis of human mesenchymal stem cells(MSCs) induced by H2O2 and the correlated cell signaling pathways.Methods:After being cultured in vitro,human MSCs were treated with pravastatin.Protein and phosphorylation of ERK 1/2,p38 MAPK and PI3K/Akt were detected by Western blotting.After 1 hour pretreatment with 10 μmol/L pravastatin,cells were cultured in presence of 1 mmol/L H2O2 for 1 hour.Cell morphology was observed under the inverted microscope.After pretreatment with inhibitors or agonists of ERK 1/2,p38 MAPK and PI3K/Akt,cell apoptosis was determined by flow cytometry.Results: Pravastatin could increase phosphorylation of PI3K/Akt pathway of human MSCs,but reduce phosphorylation of p38MAPK,and it had no obvious effect on ERK1/2 pathway and total proteins of Akt and p38MAPK.Pravastatin could decrease human MSCs apoptosis induced by H2O2(P<0.05) and the inhibitory effect was abrogated by Ly294002 but not anisomysin.Conclusions: Pravastatin can activate PI3K/Akt pathway and inhibit p38 MAPK pathway of human MSCs.Furthermore,it can protect MSCs from apoptosis induced by H2O2.Activation of PI3K/Akt pathway is involved in the effect of pravastatin on apoptosis.
What problem does this paper attempt to address?